Insider Trading & Ownership - BREITMEYER JAMES B

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for BREITMEYER JAMES B
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2023-04-13
Purchase
2023-04-17
06:00 am
Oncternal Therapeutics Inc.ONCTBREITMEYER JAMES B
Chief Executive Officer
150,000$0.29286$43,930763,176
(Indirect
Direct)
View
2022-01-27
Purchase
2022-01-31
4:00 pm
Oncternal Therapeutics Inc.ONCTBREITMEYER JAMES B
Chief Executive Officer
25,000$1.6832$42,080437,919
(Indirect
Direct)
View
2019-12-16
Sale
2019-12-18
4:07 pm
ZOGENIX INC.ZGNXBREITMEYER JAMES B
Director
5,000$50$250,00011,250
(Direct)
View
2019-11-25
Sale
2019-11-27
4:13 pm
ZOGENIX INC.ZGNXBREITMEYER JAMES B
Director
5,000$50$250,00016,250
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-02-14
Option Award
2024-02-15
6:00 pm
N/A
2034-02-14
Oncternal Therapeutics Inc.ONCTBREITMEYER JAMES B
Chief Executive Officer
34,600$034,600
(Direct)
View
2024-01-03
Tax Withholding
2024-01-05
4:00 pm
N/A
N/A
Oncternal Therapeutics Inc.ONCTBREITMEYER JAMES B
Chief Executive Officer
55,440$0.4961655,737
(Direct)
View
2023-10-02
Option Award
2023-10-04
5:00 pm
N/A
2029-09-12
Oncternal Therapeutics Inc.ONCTBREITMEYER JAMES B
Chief Executive Officer
2,601,140$02,591,380
(Direct)
View
2023-10-02
Disposition
2023-10-04
5:00 pm
N/A
2029-09-12
Oncternal Therapeutics Inc.ONCTBREITMEYER JAMES B
Chief Executive Officer
2,601,140$02,591,380
(Direct)
View
2023-07-03
Tax Withholding
2023-07-05
6:59 pm
N/A
N/A
Oncternal Therapeutics Inc.ONCTBREITMEYER JAMES B
Chief Executive Officer
51,999$0.36711,177
(Direct)
View
2023-02-21
Option Award
2023-02-24
4:00 pm
N/A
2033-02-21
Oncternal Therapeutics Inc.ONCTBREITMEYER JAMES B
Chief Executive Officer
757,196$0757,196
(Direct)
View
2023-01-03
Tax Withholding
2023-01-05
6:00 pm
N/A
N/A
Oncternal Therapeutics Inc.ONCTBREITMEYER JAMES B
Chief Executive Officer
29,118$1.02613,176
(Direct)
View
2022-07-28
Option Award
2022-08-01
6:18 pm
N/A
2032-07-28
Oncternal Therapeutics Inc.ONCTBREITMEYER JAMES B
Chief Executive Officer
340,625$0778,544
(Direct)
View
2022-06-21
Option Award
2022-06-23
4:30 pm
N/A
2032-06-20
OTONOMY INC.OTICBREITMEYER JAMES B
Director
27,500$027,500
(Direct)
View
2022-03-07
Equity Swap
2022-03-09
7:16 pm
N/A
N/A
ZOGENIX INC.ZGNXBREITMEYER JAMES B
Director
1,250$00
(Direct)
View
2022-03-07
Disposition
2022-03-09
7:16 pm
N/A
2024-03-24
ZOGENIX INC.ZGNXBREITMEYER JAMES B
Director
76,625$00
(Direct)
View
2022-01-20
Option Award
2022-01-24
4:14 pm
N/A
2032-01-20
Oncternal Therapeutics Inc.ONCTBREITMEYER JAMES B
Chief Executive Officer
802,000$0802,000
(Direct)
View
2022-01-03
Option Award
2022-01-05
7:00 pm
N/A
N/A
Oncternal Therapeutics Inc.ONCTBREITMEYER JAMES B
Chief Executive Officer
135,350$0413,219
(Direct)
View
2021-06-22
Option Award
2021-06-24
5:00 pm
N/A
2031-06-21
OTONOMY INC.OTICBREITMEYER JAMES B
Director
17,500$017,500
(Direct)
View
2021-05-27
Option Award
2021-05-28
8:03 pm
N/A
2031-05-27
ZOGENIX INC.ZGNXBREITMEYER JAMES B
Director
22,000$022,000
(Direct)
View
2021-03-18
Option Award
2021-03-22
4:00 pm
N/A
2028-11-14
Oncternal Therapeutics Inc.ONCTBREITMEYER JAMES B
Chief Executive Officer
63,295$0105,492
(Direct)
View
2021-01-27
Option Award
2021-02-23
8:12 pm
N/A
2031-01-27
Oncternal Therapeutics Inc.ONCTBREITMEYER JAMES B
Chief Executive Officer
9,000$09,000
(Indirect)
View
2021-02-11
Option Award
2021-02-16
6:00 pm
N/A
2031-02-11
Oncternal Therapeutics Inc.ONCTBREITMEYER JAMES B
Chief Executive Officer
750,000$0750,000
(Direct)
View
2020-03-17
Option Award(A)
2020-07-31
9:05 pm
N/A
2030-03-17
Oncternal Therapeutics Inc.ONCTBREITMEYER JAMES B
Chief Executive Officer
66,890$066,890
(Direct)
View
2020-01-07
Option Award(A)
2020-07-31
9:05 pm
N/A
2030-01-07
Oncternal Therapeutics Inc.ONCTBREITMEYER JAMES B
Chief Executive Officer
22,000$022,000
(Indirect)
View
2020-05-29
Option Award
2020-06-29
9:12 pm
N/A
2030-05-29
ZOGENIX INC.ZGNXBREITMEYER JAMES B
Director
13,000$013,000
(Direct)
View
2020-06-23
Option Award
2020-06-25
5:07 pm
N/A
2030-06-22
OTONOMY INC.OTICBREITMEYER JAMES B
Director
17,500$017,500
(Direct)
View
2020-03-17
Option Award
2020-03-18
6:52 pm
N/A
2030-03-17
Oncternal Therapeutics Inc.ONCTBREITMEYER JAMES B
Chief Executive Officer
66,890$066,890
(Direct)
View
2020-01-07
Option Award
2020-01-09
4:00 pm
N/A
2030-01-07
Oncternal Therapeutics Inc.ONCTBREITMEYER JAMES B
Chief Executive Officer
22,000$022,000
(Indirect)
View
2019-12-16
Exercise
2019-12-18
4:07 pm
N/A
2026-07-12
ZOGENIX INC.ZGNXBREITMEYER JAMES B
Director
5,000$011,250
(Direct)
View
2019-12-16
Exercise
2019-12-18
4:07 pm
N/A
N/A
ZOGENIX INC.ZGNXBREITMEYER JAMES B
Director
5,000$8.9911,250
(Direct)
View
2019-11-25
Exercise
2019-11-27
4:13 pm
N/A
2026-07-12
ZOGENIX INC.ZGNXBREITMEYER JAMES B
Director
5,000$016,250
(Direct)
View
2019-11-25
Exercise
2019-11-27
4:13 pm
N/A
N/A
ZOGENIX INC.ZGNXBREITMEYER JAMES B
Director
5,000$8.9916,250
(Direct)
View
(A) Indicate amendment filing.